Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Aug 21;57(9):765-776.
doi: 10.1093/abm/kaad024.

Effect of the Fit2Thrive Intervention on Patient-reported Outcomes in Breast Cancer Survivors: A Randomized Full Factorial Trial

Affiliations
Randomized Controlled Trial

Effect of the Fit2Thrive Intervention on Patient-reported Outcomes in Breast Cancer Survivors: A Randomized Full Factorial Trial

Payton Solk et al. Ann Behav Med. .

Abstract

Background: Moderate to vigorous physical activity (MVPA) interventions improve patient-reported outcomes (PROs) of physical and psychological health among breast cancer survivors (BCS); however, the effects of specific intervention components on PROs are unknown.

Purpose: To use the Multiphase Optimization Strategy (MOST) to examine overall effects of the Fit2Thrive MVPA promotion intervention on PROs in BCS and explore whether there are intervention component-specific effects on PROs.

Methods: Physically inactive BCS [n = 269; Mage = 52.5 (SD = 9.9)] received a core intervention (Fitbit + Fit2Thrive smartphone app) and were randomly assigned to one of 32 conditions in a full factorial experiment of five components ("on" vs. "off"): (i) support calls, (ii) deluxe app, (iii) text messages, (iv) online gym, and (v) buddy. Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaires assessed anxiety, depression, fatigue, physical functioning, sleep disturbance and sleep-related impairment at baseline, post-intervention (12-week), and 24-week follow-up. Main effects for all components at each time point were examined using an intention to treat mixed-effects model.

Results: All PROMIS measures except sleep disturbance significantly improved (p's < .008 for all) from baseline to 12-weeks. Effects were maintained at 24-weeks. The "on" level of each component did not result in significantly greater improvements on any PROMIS measure compared to the "off" level.

Conclusions: Participation in Fit2Thrive was associated with improved PROs in BCS, but improvements did not differ for "on" vs. "off" levels for any component tested. The low-resource Fit2Thrive core intervention is a potential strategy to improve PROs among BCS. Future studies should test the core in an RCT and examine various intervention component effects in BCS with clinically elevated PROs.

Trial registration: ClinicalTrials.gov NCT03131440.

Keywords: Cancer survivorship; Patient-reported outcome measures; Physical activity; mHealth.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Consolidated Standards of Reporting Trials diagram depicting participant flow through study.

References

    1. American Cancer Society. Cancer Treatment and Survivorship Facts and Figures 2022–2024. Atlanta: American Cancer Society; 2022.
    1. Ribeiro FE, Vanderlei LCM, Palma MR, et al. . Body dissatisfaction and its relationship with overweight, sedentary behavior and physical activity in survivors of breast cancer. Eur J Obstet Gynecol Reprod Biol. 2018; 229:153–158. doi:10.1016/j.ejogrb.2018.08.581. - DOI - PubMed
    1. Lovelace DL, McDaniel LR, Golden D.. Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health. 2019; 64(6):713–724. doi:10.1111/jmwh.13012. - DOI - PubMed
    1. Servaes P, Verhagen S, Bleijenberg G.. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 2002; 13(4):589–598. doi:10.1093/annonc/mdf082. - DOI - PubMed
    1. Winters-Stone KM, Medysky ME, Savin MA.. Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls. J Geriatr Oncol. 2019; 10(2):311–316. doi:10.1016/j.jgo.2018.10.006. - DOI - PMC - PubMed

Publication types

Associated data